Beardsley Robert A
Insider CIK 1310845 · ABUS Director · GRTX Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABUS Arbutus Biopharma Corp | D To issuer | 2026-10-01 | 2026-10-07 | 17,948 | $5.00 | $89.7K | 14,328 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise deriv | 2026-09-18 | 2026-09-23 | 78,800 | — | $0 | 0 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise deriv | 2026-09-18 | 2026-09-23 | 52,533 | — | $0 | 105,067 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise | 2026-09-18 | 2026-09-23 | 78,800 | $4.24 | $334.1K | 131,333 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise | 2026-09-18 | 2026-09-23 | 52,533 | $3.20 | $168.1K | 52,533 | SEC↗ |
| ABUS Arbutus Biopharma Corp | F Tax w/h | 2026-09-18 | 2026-09-23 | 99,057 | $5.07 | $502.2K | 32,276 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise deriv | 2026-09-18 | 2026-09-23 | 78,800 | — | $0 | 0 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise deriv | 2026-09-18 | 2026-09-23 | 52,533 | — | $0 | 105,067 | SEC↗ |
| ABUS Arbutus Biopharma Corp | F Tax w/h | 2026-09-18 | 2026-09-23 | 99,057 | $5.07 | $502.2K | 32,276 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise | 2026-09-18 | 2026-09-23 | 78,800 | $4.24 | $334.1K | 131,333 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise | 2026-09-18 | 2026-09-23 | 52,533 | $3.20 | $168.1K | 52,533 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2026-06-08 | 2026-06-10 | 78,800 | — | $0 | 78,800 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2025-03-18 | 2025-03-20 | 157,600 | — | $0 | 157,600 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2023-02-25 | 2023-02-28 | 135,000 | — | $0 | 135,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | M Exercise deriv | 2022-11-21 | 2022-11-22 | 10,000 | — | $0 | 75,651 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | M Exercise | 2022-11-21 | 2022-11-22 | 10,000 | $1.07 | $10.7K | 108,191 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | M Exercise deriv | 2022-09-12 | 2022-09-13 | 10,000 | — | $0 | 85,651 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | M Exercise | 2022-09-12 | 2022-09-13 | 10,000 | $1.07 | $10.7K | 98,191 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2022-02-28 | 2022-03-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | M Exercise deriv | 2021-12-17 | 2021-12-20 | 20,000 | — | $0 | 95,651 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | M Exercise | 2021-12-17 | 2021-12-20 | 20,000 | $1.07 | $21.4K | 88,191 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2021-01-26 | 2021-01-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2020-01-31 | 2020-02-04 | 74,435 | — | $0 | 74,435 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 6,774 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 2,000 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 68,907 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-12 | 15,361 | — | $0 | 68,191 | SEC↗ |